134 related articles for article (PubMed ID: 24007689)
1. Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.
Crawford S
Int J Drug Policy; 2013 Nov; 24(6):e14-7. PubMed ID: 24007689
[TBL] [Abstract][Full Text] [Related]
2. The politics of providing opioid pharmacotherapy.
Radcliffe P; Parkes T
Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
[No Abstract] [Full Text] [Related]
3. Methadone, a contested substance: Danish methadone policy in the 1970s.
Houborg E
Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
[TBL] [Abstract][Full Text] [Related]
4. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
Bernstein SE; Bennett D
Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
[TBL] [Abstract][Full Text] [Related]
5. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
[TBL] [Abstract][Full Text] [Related]
6. The role of the Chinese police in methadone maintenance therapy: a literature review.
Meng J; Burris S
Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
[TBL] [Abstract][Full Text] [Related]
7. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
Treloar C; Valentine K
Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
[No Abstract] [Full Text] [Related]
8. Opioid pharmacotherapy: Treatment, regimes, constructions and control.
Neale J
Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399
[No Abstract] [Full Text] [Related]
9. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
Monaghan M; Wincup E
Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
[TBL] [Abstract][Full Text] [Related]
10. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
Madden A; Lea T; Bath N; Winstock AR
Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
[TBL] [Abstract][Full Text] [Related]
11. The marketing of methadone: how an effective medication became unpopular.
Bruce RD
Int J Drug Policy; 2013 Nov; 24(6):e89-90. PubMed ID: 24246504
[No Abstract] [Full Text] [Related]
12. Response to Chandler et al., Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Valentine K; Treloar C
Int J Drug Policy; 2013 Nov; 24(6):e87-8. PubMed ID: 23931956
[No Abstract] [Full Text] [Related]
13. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
Salsitz E; Wiegand T
J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel.
Shidlansik L; Adelson M; Peles E
J Addict Dis; 2017; 36(1):30-37. PubMed ID: 27636020
[TBL] [Abstract][Full Text] [Related]
16. Categorising methadone: Addiction and analgesia.
Keane H
Int J Drug Policy; 2013 Nov; 24(6):e18-24. PubMed ID: 23768774
[TBL] [Abstract][Full Text] [Related]
17. Dealing with aggressive methadone patients in community pharmacy: a critical incident study.
Irwin A; Laing C; Mearns K
Res Social Adm Pharm; 2012; 8(6):542-51. PubMed ID: 22381914
[TBL] [Abstract][Full Text] [Related]
18. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia.
Winstock AR; Lea T
Subst Use Misuse; 2010; 45(1-2):240-52. PubMed ID: 20025451
[TBL] [Abstract][Full Text] [Related]
19. Excusing exclusion: Accounting for rule-breaking and sanctions in a Swedish methadone clinic.
Petersson FJ
Int J Drug Policy; 2013 Nov; 24(6):e99-e104. PubMed ID: 24183330
[TBL] [Abstract][Full Text] [Related]
20. From Narcotic to Normalizer: The Misperception of Methadone Treatment and the Persistence of Prejudice and Bias.
Woods JS; Joseph H
Subst Use Misuse; 2018 Jan; 53(2):323-329. PubMed ID: 29236562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
